Product identification
DRP-RT3 is listed as a code-labeled, lyophilized laboratory research material with a labeled amount of 40 mg. The page is limited to catalog identification, availability, and analytical documentation.
Laboratory research material
DRP-RT3 40 mg
Lyophilized research material
$95
| Quantity | Price each | Discount |
|---|---|---|
| 1–4 vials | $95.00 | — |
| 5–9 vials | $88.35 | 7% off |
| 10+ vials | $80.75 | 15% off |
This page records the current DAAVY Research DRP-RT3 catalog identity, labeled amount, price, availability, and COA reference. The content remains limited to research-product and documentation information.
- Labeled amount
- 40 mg
- Testing
- Third-party testing complete
- COA
- COA7574 · Bioviridians
- Use restriction
- For Research Purposes Only
Research background
DRP-RT3 is a synthetic peptide engineered to interact with multiple metabolic receptor systems, including GLP-1, GIP, and glucagon receptors. In laboratory studies, this compound is utilized for examining receptor binding dynamics and endocrine pathway signaling. DRP-RT3 is synthesized via solid-phase peptide synthesis and undergoes multi-stage purification to ensure high-purity analytical standards suitable for controlled research environments. This catalog listing has not been evaluated for the purposes described in this research. DAAVY Research supplies this material only for legitimate laboratory, analytical, academic, or institutional research; it is not intended for human or veterinary use, consumption, diagnosis, treatment, or prevention.
Analytical documentation
The current listing includes third-party Certificate of Analysis COA7574. Researchers should review the document directly for the methods and reported results associated with the tested sample.
Research-use controls
This material is supplied only for legitimate laboratory, analytical, academic, or institutional research. It is not intended for human or veterinary use or consumption, diagnosis, treatment, or prevention.